RAPGEF4 and neuroblastoma: Since 8-pCPT is an agonist of Epac1 and we have shown it to lead to a significant decrease in the number of transmigrated cells (Fig 4), it was important to test the effect of Epac inhibitors on 8-pCPT augmentation of the trans-endothelial migration of NB cells.